Internal Medicine, Rheumatology · Longmont, CO
NPI
1629120761
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1715 Iron Horse Dr Ste 100
Longmont, CO, 80501
Phone (720) 494-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$474K
27,498 services
Medicare patients, 2024
320
Average age 74
Drug cost, 2024
$2.4M
3,087 prescriptions
Company payments, 2024
$15.67
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jill Gibson was code J3111 (injection, romosozumab-aqqg, 1 mg), 7,350 times for 18 patients. In total Jill Gibson billed 27,498 services in 35 codes, and Medicare paid $474K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 7,350 | 18 | $8.53 | $63K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,525 | 21 | $33.80 | $221K |
| J0897 Injection, denosumab, 1 mg | Office | 2,640 | 34 | $20.23 | $53K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 764 | 16 | $0.09 | $68.52 |
| 99214 Office E&M - Established | Office | 465 | 217 | $84.48 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 443 | 227 | $11.24 | $4,981 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 140 | 28 | $4.75 | $665 |
| 96365 Intravenous Infusion, Hydration | Office | 126 | 52 | $50.70 | $6,388 |
| 96372 Injection Administration | Office | 57 | 37 | $11.49 | $655 |
| 99213 Office E&M - Established | Office | 52 | 44 | $66.28 | $3,446 |
| 96401 Chemotherapy Administration | Office | 44 | 25 | $57.12 | $2,513 |
| 96413 Chemotherapy Administration | Office | 31 | 15 | $105.60 | $3,274 |
By year: 2022 $510K for 36,393 services; 2023 $438K for 31,812 services; 2024 $474K for 27,498 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 114 | 96 | $2.97 | $338 |
Medicare prescription drug claims, 2024
In 2024, the drug Jill Gibson prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 381 prescriptions and refills. In total Jill Gibson wrote 3,087 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 381 | 1,003 | 116 | $15K |
| Methotrexate Methotrexate Sodium | 372 | 926 | 111 | $9,399 |
| Prednisone Generic | 272 | 479 | 85 | $2,632 |
| Tramadol Hcl Generic | 157 | 157 | 34 | $2,028 |
| Folic Acid Generic | 126 | 379 | 42 | $1,573 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 118 | 118 | 21 | $4,608 |
| Gabapentin Generic | 106 | 218 | 32 | $2,238 |
| Duloxetine Hcl Generic | 104 | 274 | 35 | $3,042 |
| Leflunomide Generic | 92 | 238 | 28 | $7,174 |
| Alendronate Sodium Generic | 90 | 252 | 28 | $645 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 81 | 81 | 11 | $2,217 |
| Enbrel Sureclick Etanercept | 75 | 79 | Under 11 | $609K |
| Diclofenac Sodium Generic | 69 | 120 | 24 | $2,916 |
| Sulfasalazine Dr Sulfasalazine | 68 | 137 | 16 | $2,496 |
| Allopurinol Generic | 66 | 195 | 17 | $649 |
Brand drugs: - claims; generic drugs: 2,650 claims; opioid claims: 454.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jill Gibson $15.67 ($15.67 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $15.67.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $15.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.